Annual EBIT
-$15.97 M
+$65.90 K+0.41%
December 31, 2022
Summary
- As of February 10, 2025, DFFN annual earnings before interest & taxes is -$15.97 million, with the most recent change of +$65.90 thousand (+0.41%) on December 31, 2022.
- During the last 3 years, DFFN annual EBIT has fallen by -$4.42 million (-38.27%).
Performance
DFFN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBIT
-$2.29 M
+$1.97 M+46.26%
June 30, 2023
Summary
- As of February 10, 2025, DFFN quarterly earnings before interest & taxes is -$2.29 million, with the most recent change of +$1.97 million (+46.26%) on June 30, 2023.
- Over the past year, DFFN quarterly EBIT has increased by +$1.95 million (+46.00%).
Performance
DFFN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBIT
-$13.73 M
+$1.95 M+12.45%
June 30, 2023
Summary
- As of February 10, 2025, DFFN TTM earnings before interest & taxes is -$13.73 million, with the most recent change of +$1.95 million (+12.45%) on June 30, 2023.
- Over the past year, DFFN TTM EBIT has increased by +$2.59 million (+15.87%).
Performance
DFFN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
DFFN EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.4% | +46.0% | +15.9% |
| 3 y3 years | -38.3% | +37.3% | -8.8% |
| 5 y5 years | -40.7% | +25.5% | -18.9% |
DFFN EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +0.4% | at high | +98.7% | at high | +18.9% |
| 5 y | 5-year | +38.3% | +0.4% | at high | +130.0% | +18.9% | +30.2% |
| alltime | all time | -2705.6% | +41.5% | -114.3% | +821.2% | -192.0% | +193.5% |
Diffusion Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$2.29 M(-46.3%) | -$13.73 M(-12.5%) |
| Mar 2023 | - | -$4.27 M(+0.4%) | -$15.68 M(-1.8%) |
| Dec 2022 | -$15.97 M(-0.4%) | -$4.25 M(+45.4%) | -$15.97 M(+5.2%) |
| Sep 2022 | - | -$2.92 M(-31.2%) | -$15.19 M(-6.9%) |
| Jun 2022 | - | -$4.25 M(-6.8%) | -$16.32 M(+2.6%) |
| Mar 2022 | - | -$4.55 M(+31.4%) | -$15.91 M(-0.8%) |
| Dec 2021 | -$16.04 M(+0.4%) | -$3.47 M(-14.5%) | -$16.04 M(-3.7%) |
| Sep 2021 | - | -$4.05 M(+5.8%) | -$16.66 M(-6.8%) |
| Jun 2021 | - | -$3.83 M(-18.2%) | -$17.88 M(+1.0%) |
| Mar 2021 | - | -$4.68 M(+14.6%) | -$17.70 M(+10.8%) |
| Dec 2020 | -$15.97 M(+38.3%) | -$4.09 M(-22.5%) | -$15.97 M(+7.6%) |
| Sep 2020 | - | -$5.27 M(+44.2%) | -$14.85 M(+17.6%) |
| Jun 2020 | - | -$3.66 M(+23.8%) | -$12.63 M(+9.0%) |
| Mar 2020 | - | -$2.96 M(-0.1%) | -$11.59 M(+0.3%) |
| Dec 2019 | -$11.55 M(-4.0%) | -$2.96 M(-3.0%) | -$11.55 M(+1.3%) |
| Sep 2019 | - | -$3.05 M(+16.4%) | -$11.41 M(+2.4%) |
| Jun 2019 | - | -$2.62 M(-10.2%) | -$11.14 M(-3.9%) |
| Mar 2019 | - | -$2.92 M(+3.7%) | -$11.60 M(-3.6%) |
| Dec 2018 | -$12.03 M(+6.0%) | -$2.81 M(+1.0%) | -$12.03 M(+3.1%) |
| Sep 2018 | - | -$2.79 M(-9.5%) | -$11.67 M(-4.6%) |
| Jun 2018 | - | -$3.08 M(-8.1%) | -$12.23 M(+0.8%) |
| Mar 2018 | - | -$3.35 M(+36.6%) | -$12.13 M(+6.9%) |
| Dec 2017 | -$11.35 M(-38.2%) | -$2.45 M(-26.7%) | -$11.35 M(-0.8%) |
| Sep 2017 | - | -$3.35 M(+12.2%) | -$11.44 M(-17.7%) |
| Jun 2017 | - | -$2.98 M(+16.1%) | -$13.89 M(-5.6%) |
| Mar 2017 | - | -$2.57 M(+1.0%) | -$14.71 M(-19.9%) |
| Dec 2016 | -$18.37 M(+186.8%) | -$2.54 M(-56.2%) | -$18.36 M(-0.1%) |
| Sep 2016 | - | -$5.80 M(+52.6%) | -$18.39 M(+32.0%) |
| Jun 2016 | - | -$3.80 M(-38.9%) | -$13.94 M(+21.9%) |
| Mar 2016 | - | -$6.22 M(+142.2%) | -$11.44 M(+78.5%) |
| Dec 2015 | -$6.41 M(-62.1%) | -$2.57 M(+90.8%) | -$6.41 M(-43.5%) |
| Sep 2015 | - | -$1.35 M(+3.7%) | -$11.35 M(-16.0%) |
| Jun 2015 | - | -$1.30 M(+8.8%) | -$13.51 M(-19.2%) |
| Mar 2015 | - | -$1.19 M(-84.1%) | -$16.72 M(-0.8%) |
| Dec 2014 | -$16.90 M | -$7.51 M(+114.0%) | -$16.84 M(+56.7%) |
| Sep 2014 | - | -$3.51 M(-22.1%) | -$10.75 M(+21.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | -$4.51 M(+240.8%) | -$8.85 M(+382.2%) |
| Mar 2014 | - | -$1.32 M(-6.3%) | -$1.84 M(-35.4%) |
| Dec 2013 | -$2.84 M(-57.5%) | -$1.41 M(-12.6%) | -$2.84 M(-119.5%) |
| Sep 2013 | - | -$1.61 M(-164.3%) | $14.58 M(-2.3%) |
| Jun 2013 | - | $2.51 M(-207.9%) | $14.93 M(-271.5%) |
| Mar 2013 | - | -$2.33 M(-114.5%) | -$8.70 M(+30.3%) |
| Dec 2012 | -$6.68 M(-70.4%) | $16.01 M(-1361.0%) | -$6.68 M(-82.1%) |
| Sep 2012 | - | -$1.27 M(-94.0%) | -$37.43 M(-7.1%) |
| Jun 2012 | - | -$21.12 M(+6828.7%) | -$40.30 M(+89.8%) |
| Mar 2012 | - | -$304.80 K(-97.9%) | -$21.24 M(-6.1%) |
| Dec 2011 | -$22.61 M(+171.4%) | -$14.73 M(+255.9%) | -$22.61 M(+95.9%) |
| Sep 2011 | - | -$4.14 M(+101.3%) | -$11.54 M(+27.6%) |
| Jun 2011 | - | -$2.06 M(+22.8%) | -$9.04 M(+2.7%) |
| Mar 2011 | - | -$1.67 M(-54.4%) | -$8.81 M(+5.7%) |
| Dec 2010 | -$8.33 M(+154.0%) | -$3.67 M(+123.3%) | -$8.33 M(+33.1%) |
| Sep 2010 | - | -$1.64 M(-9.7%) | -$6.26 M(+20.8%) |
| Jun 2010 | - | -$1.82 M(+52.2%) | -$5.18 M(+36.8%) |
| Mar 2010 | - | -$1.20 M(-25.2%) | -$3.79 M(+27.4%) |
| Dec 2009 | -$3.28 M(+171.5%) | -$1.60 M(+181.6%) | -$2.97 M(+65.3%) |
| Sep 2009 | - | -$567.80 K(+33.4%) | -$1.80 M(+18.4%) |
| Jun 2009 | - | -$425.70 K(+11.8%) | -$1.52 M(+14.5%) |
| Mar 2009 | - | -$380.90 K(-10.3%) | -$1.33 M(+9.9%) |
| Dec 2008 | -$1.21 M(+2063.8%) | -$424.60 K(+47.3%) | -$1.21 M(-4007.1%) |
| Sep 2008 | - | -$288.20 K(+23.5%) | $30.90 K(-81.7%) |
| Jun 2008 | - | -$233.30 K(-10.7%) | $169.30 K(+125.4%) |
| Mar 2008 | - | -$261.20 K(-132.1%) | $75.10 K(-234.6%) |
| Dec 2007 | -$55.80 K(+33.2%) | $813.60 K(-643.1%) | -$55.80 K(-93.8%) |
| Sep 2007 | - | -$149.80 K(-54.3%) | -$900.50 K(+19.4%) |
| Jun 2007 | - | -$327.50 K(-16.5%) | -$754.30 K(+60.0%) |
| Mar 2007 | - | -$392.10 K(+1160.8%) | -$471.50 K(+468.1%) |
| Dec 2006 | -$41.90 K(-54.6%) | -$31.10 K(+763.9%) | -$83.00 K(+59.9%) |
| Sep 2006 | - | -$3600.00(-91.9%) | -$51.90 K(+7.5%) |
| Jun 2006 | - | -$44.70 K(+1141.7%) | -$48.30 K(+1241.7%) |
| Mar 2006 | - | -$3600.00 | -$3600.00 |
| Dec 2005 | -$92.20 K(-98.7%) | - | - |
| Dec 1999 | -$7.22 M(-1278.5%) | - | - |
| Dec 1998 | $613.00 K | - | - |
FAQ
- What is Diffusion Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Diffusion Pharmaceuticals?
- What is Diffusion Pharmaceuticals annual EBIT year-on-year change?
- What is Diffusion Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Diffusion Pharmaceuticals?
- What is Diffusion Pharmaceuticals quarterly EBIT year-on-year change?
- What is Diffusion Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Diffusion Pharmaceuticals?
- What is Diffusion Pharmaceuticals TTM EBIT year-on-year change?
What is Diffusion Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of DFFN is -$15.97 M
What is the all time high annual EBIT for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals all-time high annual earnings before interest & taxes is $613.00 K
What is Diffusion Pharmaceuticals annual EBIT year-on-year change?
Over the past year, DFFN annual earnings before interest & taxes has changed by +$65.90 K (+0.41%)
What is Diffusion Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of DFFN is -$2.29 M
What is the all time high quarterly EBIT for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals all-time high quarterly earnings before interest & taxes is $16.01 M
What is Diffusion Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, DFFN quarterly earnings before interest & taxes has changed by +$1.95 M (+46.00%)
What is Diffusion Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of DFFN is -$13.73 M
What is the all time high TTM EBIT for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals all-time high TTM earnings before interest & taxes is $14.93 M
What is Diffusion Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, DFFN TTM earnings before interest & taxes has changed by +$2.59 M (+15.87%)